Sitagliptin ameliorates the progression of atherosclerosis via down regulation of the inflammatory and oxidative pathways

BACK GROUND: Atherosclerosis is the major cause of death. The most common risk factors are hyperlipidemia, diabetes, and other factors like chronic infection and inflammation. OBJECTIVE: This study was undertaken to assess the effect of sitagliptin on atherosclerosis via interfering with inflammator...

Full description

Saved in:
Bibliographic Details
Published in:SAGE Open Med
Main Authors: Majeed, Sahar A, Hadi, Najah R, Al Mudhafar, Ahmed M, Al-Janabi, Hussein A
Format: Artigo
Language:Inglês
Published: SAGE Publications 2013
Subjects:
Original Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC4687767/
https://ncbi.nlm.nih.gov/pubmed/26770677
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2050312113499912
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items